UFP Technologies will report its second-quarter results tomorrow after market hours. The medical products company met revenue expectations last quarter with $154.2 million, a 4.1% year-on-year increase, and beat EPS estimates. For this quarter, analysts expect revenue growth of 5.4% year-on-year, a slowdown from the 37.2% growth in the same quarter last year. UFP Technologies has missed Wall Street revenue estimates multiple times over the past two years, and its stock is down 6.3% over the last month heading into earnings with an average analyst price target of $324.50 compared to the current share price of $254.78.
UFP Technologies IncQ2 earnings report upcoming; past misses and stock decline create uncertainty.